As of Sep 23
| -0.04 / -2.31%|
The 2 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 2.25, with a high estimate of 2.50 and a low estimate of 2.00. The median estimate represents a +33.14% increase from the last price of 1.69.
The current consensus among 2 polled investment analysts is to Hold stock in MEI Pharma Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.